GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Capex-to-Operating-Income

GUTS (Fractyl Health) Capex-to-Operating-Income : 0.00 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Fractyl Health's Capital Expenditure for the three months ended in Mar. 2025 was $-0.45 Mil. Its Operating Income for the three months ended in Mar. 2025 was $-24.76 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Fractyl Health Capex-to-Operating-Income Historical Data

The historical data trend for Fractyl Health's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fractyl Health Capex-to-Operating-Income Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Fractyl Health Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Fractyl Health's Capex-to-Operating-Income

For the Biotechnology subindustry, Fractyl Health's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fractyl Health's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Capex-to-Operating-Income falls into.


;
;

Fractyl Health Capex-to-Operating-Income Calculation

Fractyl Health's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-1.765) / -93.531
=N/A

Fractyl Health's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.448) / -24.759
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fractyl Health  (NAS:GUTS) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Fractyl Health Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Fractyl Health Business Description

Traded in Other Exchanges
N/A
Address
3 Van de Graaff Drive, Suite 200, Burlington, MA, USA, 01803
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Executives
Adrian Kimber officer: Chief Commercial Officer C/O FRACTLY HEALTH, INC., 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON MA 01803
American International Group, Inc. 10 percent owner 1271 AVE OF THE AMERICAS, FL 37, NEW YORK NY 10020-1304
American Home Assurance Co 10 percent owner
Corebridge Deco Ii, Llc 10 percent owner 28 LIBERTY STREET, 47TH FLOOR, NEW YORK NY 10005
Allan R Will director C/O FRACTYL LABORATORIES INC., 203 CRESCENT ST., SUITE 303, WALTHAM MA 02453
Mithril Ii Lp 10 percent owner ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900, SAN FRANCISCO CA 94129
Ajay Royan director, 10 percent owner 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Mithril Ii Ugp Llc 10 percent owner 600 CONGRESS AVENUE, SUITE 3100, AUSTIN TX 78701
Mithril Ii Gp Lp 10 percent owner 111 CONGRESS STREET, SUITE 500, AUSTIN TX 78701
Mithril Gp Lp 10 percent owner C/O MITHRIL CAPITAL MANAGEMENT LLC, 600 CONGRESS AVENUE, SUITE 3100, AUSTIN TX 78701
Clive Meanwell director THE MEDICINES CO, 8 SYLVAN WAY, PARSIPPANY NJ 07054
M28 Capital Management Lp director 700 CANAL STREET, 2ND FLOOR, STAMFORD CT 06902
Marc Elia director C/O SQZ BIOTECHNOLOGIES COMPANY, 200 ARSENAL YARDS BOULEVARD, SUITE 210, WATERTOWN MA 02472
Jay David Caplan officer: President, Chief Product Off. 34 CLARK STREET, BELMONT MA 02478
Lisa Davidson officer: Chief Financial Officer C/O FRACTYL LABORATORIES INC., 203 CRESCENT ST., SUITE 303, WALTHAM MA 02453

Fractyl Health Headlines